Form 8-K · Current Report · Filed 2026-03-23
Cencora Announces Acquisition of EyeSouth Partners' Retina Business
Cencora, Inc. has entered into a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The acquisition, which is expected to be slightly accretive to Cencora's adjusted diluted EPS in the first twelve months following closing, will see the affiliated retina physicians of EyeSouth Partners join Cencora's Retina Consultants of America (RCA). The transaction is subject to customary closing conditions, including regulatory approvals, and is not expected to impact Cencora's reaffirmed fiscal 2026 financial guidance.
- Filer
- Cencora Inc. COR · NYSE
- Filed
- Accession
- 0001104659-26-033022
- CIK
- 0001140859
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$326.91
Next session
+0.1%
Since filing
-4.8%
Latest close
$311.34
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from COR reporting the same item, with the next session's move:
About Cencora Inc.
Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.
Never miss another COR filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.